Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Basilea Receives BARDA Contract to Develop Ceftibuten-ledaborbactam with Up to $159 Million in Funding

Sep 25, 2025•9 months ago

Contract Type

contract

Basel LandschaftBiotechnologyBiopharmaresearch

Description

Basilea Pharmaceutica has been awarded a contract from the Biomedical Advanced Research and Development Authority (BARDA) to develop the novel antibiotic ceftibuten-ledaborbactam. The contract includes non-dilutive funding of up to $159 million, enabling the company to advance its clinical studies for the treatment of complicated urinary tract infections.

Company Information

Company

Basilea Pharmaceutica Ltd

Location

175 Hegenheimermattweg

Basel Landschaft, Switzerland

About

Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company dedicated to meeting the needs of patients with severe bacterial and fungal infections.

Predictive Intelligence
Strategic

ML-powered predictions for Basilea Pharmaceutica Ltd's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.